Health-related quality of life during bosutinib (SKI-606) therapy in patients with advanced chronic myeloid leukemia after imatinib failure

Jennifer Whiteley, Arlene Reisman, Mark Shapiro, Jorge E. Cortes, David Cella

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Fingerprint

Dive into the research topics of 'Health-related quality of life during bosutinib (SKI-606) therapy in patients with advanced chronic myeloid leukemia after imatinib failure'. Together they form a unique fingerprint.

Medicine & Life Sciences